APA

Cursino C. N., Monteiro P. G. d. O., Duarte G. d. S., Vieira T. B. Q., Crisante V. d. C., Giordani F., Xavier A. R., de Almeida R. M. V. R. & Calil-Elias S. (20200727). Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C. : Pharmacoepidemiology and drug safety.

Chicago

Cursino Camille Nigri, Monteiro Priscilla Garcia de Oliveira, Duarte Gabriel da Silva, Vieira Tassita Bezz Quintanilha, Crisante Verônica de Carvalho, Giordani Fabíola, Xavier Analúcia Rampazzo, de Almeida Renan Moritz Varnier Rodrigues and Calil-Elias Sabrina. 20200727. Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C. : Pharmacoepidemiology and drug safety.

Harvard

Cursino C. N., Monteiro P. G. d. O., Duarte G. d. S., Vieira T. B. Q., Crisante V. d. C., Giordani F., Xavier A. R., de Almeida R. M. V. R. and Calil-Elias S. (20200727). Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C. : Pharmacoepidemiology and drug safety.

MLA

Cursino Camille Nigri, Monteiro Priscilla Garcia de Oliveira, Duarte Gabriel da Silva, Vieira Tassita Bezz Quintanilha, Crisante Verônica de Carvalho, Giordani Fabíola, Xavier Analúcia Rampazzo, de Almeida Renan Moritz Varnier Rodrigues and Calil-Elias Sabrina. Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C. : Pharmacoepidemiology and drug safety. 20200727.